Search

1 2005 Publications Total of 39 1. Metabolic syndrome scientific statement by the American Heart Association and the National Heart, Lung, and Blood Institute. Grundy SM. Arterioscler Thromb Vasc Biol. 2005 Nov;25(11):2243-4. No abstract available. PMID: 16258150 [PubMed - indexed for MEDLINE]Related articlesFree article 2. Trends in serum lipids and lipoproteins of adults, 1960-2002. Carroll MD, Lacher DA, Sorlie PD, Cleeman JI, Gordon DJ, Wolz M, Grundy SM, Johnson CL

Microarrays Ralph V. Shohet, M.D. Department of Internal Medicine, UTSWMC Outline 1. Types of microarrays 2. How to make one 3. How to use one Historical perspective 1. Watson-Crick basepairing 2. Southern & Northern analysis 3. Genome project Types of microarrays 1. Synthesized in situ 2. Spotted Types of microarrays 1. Synthesized in situ Short oliogonucleotides (25mers) masked and DOC particularly useful for interrogating small regions of a gene for sequence

(Bench Opinion) OCTOBER TERM, 2002 1 Syllabus NOTE: Where it is feasible, a syllabus (headnote) will be released, as is being done in connection with this case, at the time the opinion is issued. The syllabus constitutes no part of the opinion of the Court but has been prepared by the Reporter of Decisions for the convenience of the reader. See United States v. Detroit Timber & Lumber Co., 200 U. S. 321, 337. SUPREME COURT OF THE UNITED STATES Syllabus GRUTTER v. BOLLINGER ET AL

STEM CELL CLUB October 18, 2001 12:00 Noon Y6.228 Conference Room STEM CELLS, NK CELLS, and FRIEND VIRUS LEUKEMIA Michael Bennett, Department of Pathology Stem Cells: Gustavo Cudkowicz, Don Metcalf, Roger Foster, and Vinay Kumar Friend Virus: Gustavo Cudkowicz, Richard Steeves, Bob Eckner, Ed Mirand, and Vinay Kumar NK Cells: Vinay Kumar, Dorothy Yuan, Wayne Lai, PA Mathew, and John Schatzle, (faculty) Differentiation: Edwardo Luevano, John Hackett, Michelle Tutt, Tom Moore, Igor

Employees walk the walk in UTSW step challenge, winners collect a unique prize Published on: May 09, 2024 By: Lauren Warner Tags: Life @UTSW Cardiology Share: Share on Facebook Share on Twitter Share on Pinterest Share on Google Plus Share on LinkedIn From left: Gladys Paredes, B.S.N., RN, a Surgical Services nurse at William P. Clements Jr. University Hospital; Thelma Morgan, Medical Transcriptionist for Clinical Laboratory Services; Jonathan Efron, M.D., Executive Vice President for Health

TYPE 2 DIABETES MELLITUS:TYPE 2 DIABETES MELLITUS: NEW HOPE FOR PREVENTIONNEW HOPE FOR PREVENTION Robert Dobbins, M.D. Ph.D.Robert Dobbins, M.D. Ph.D. Learning ObjectivesLearning Objectives Recognize current trends in the Recognize current trends in the prevalence of type 2 diabetes.prevalence of type 2 diabetes. Learn differences between type 1 Learn differences between type 1 and type 2 diabetes.and type 2 diabetes. List risk factors for type 2 diabetes.List risk factors for type 2

Join The Vanguard as we explore the latest advances in heart disease research.

Infertility Update George R Attia, M.D Director of IVF Program University of Texas Southwestern Medical Center at Dallas Infertility • Inability to conceive after one year of adequate unprotected intercourse (six months if the woman is over age 35) Time Required for Conception in Couples Who Will Attain Pregnancy 25 45 57 72 85 93 95 0 10 20 30 40 50 60 70 80 90 100 1 month 2 months 3 months 6 months 1 Year 2 Year 3 ear % P re gn an t 35% 35% 20% 7% 3% Male

UT Southwestern faculty promotions for 2018

ß-Lapachone, a ‘Kiss of death’ therapy for cancer David A. Boothman, Ph.D. Laboratory of Molecular Stress Responses Program in Cell Stress and Cancer Nanomedicine Simmons Comprehensive Cancer Center University of Texas Southwestern Medical Center at Dallas September 14, 2008 Cellular Damage New Gene Expression Exploitable Target: Expressed in Human Tumors, not (or low) in Normal Tissues Bioactivate Drug For Tumor-Selective Killing -Not cell cycle